Back
Lineage Cell Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
LCTX
Lineage Cell Therapeutics, Inc.
Last Price:
$1.69
Seasonality Move:
11.05%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and LCTX is experiencing slight selling pressure.
Lineage Cell Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.73 | Sell |
| 20-day SMA: | 1.72 | Sell |
| 50-day SMA: | 1.74 | Sell |
| 200-day SMA: | 1.1 | Buy |
| 8-day EMA: | 1.73 | Sell |
| 20-day EMA: | 1.72 | Sell |
| 50-day EMA: | 1.56 | Buy |
| 200-day EMA: | 0.76 | Buy |
Lineage Cell Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 46.3 | Sell |
| Chaikin Money Flow: | -1199525 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.68 - 1.78) | Sell |
| Bollinger Bands (100): | (1.25 - 1.81) | Buy |
Lineage Cell Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lineage Cell Therapeutics, Inc. Stock
Is Lineage Cell Therapeutics, Inc. Stock a Buy?
-
Lineage Cell Therapeutics, Inc. share price is 1.68 while LCTX 8-day simple moving average is 1.73, which is a Sell signal.
-
The stock price of LCTX is 1.68 while Lineage Cell Therapeutics, Inc. 20-day SMA is 1.72, which makes it a Sell.
-
Lineage Cell Therapeutics, Inc. 50-day simple moving average is 1.74 while LCTX share price is 1.68, making it a Sell technically.
-
LCTX stock price is 1.68 and Lineage Cell Therapeutics, Inc. 200-day simple moving average is 1.10, creating a Buy signal.
LCTX Technical Analysis vs Fundamental Analysis
Sell
47
Lineage Cell Therapeutics, Inc. (LCTX)
is a Sell
Is Lineage Cell Therapeutics, Inc. a Buy or a Sell?
-
Lineage Cell Therapeutics, Inc. stock is rated a SellThe current Lineage Cell Therapeutics, Inc. [LCTX] share price is $1.68. The Score for LCTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Lineage Cell Therapeutics, Inc. Stock Info
Market Cap:
387M
Price in USD:
1.68
Share Volume:
4.1M
Lineage Cell Therapeutics, Inc. 52-Week Range
52-Week High:
2.09
52-Week Low:
0.37
Sell
47
Lineage Cell Therapeutics, Inc. (LCTX)
is a Sell
Lineage Cell Therapeutics, Inc. Share Price Forecast
-
What is the Lineage Cell Therapeutics, Inc. stock price today?The Lineage Cell Therapeutics, Inc. stock price is 1.68 USD today.
-
Will LCTX stock go up or go down?Lineage Cell Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Lineage Cell Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lineage Cell Therapeutics, Inc. is overvalued.
Is Lineage Cell Therapeutics, Inc. Stock a Buy?
-
Lineage Cell Therapeutics, Inc. share price is 1.68 while LCTX 8-day exponential moving average is 1.73, which is a Sell signal.
-
The stock price of LCTX is 1.68 while Lineage Cell Therapeutics, Inc. 20-day EMA is 1.72, which makes it a Sell.
-
Lineage Cell Therapeutics, Inc. 50-day exponential moving average is 1.56 while LCTX share price is 1.68, making it a Buy technically.
-
LCTX stock price is 1.68 and Lineage Cell Therapeutics, Inc. 200-day simple moving average is 0.76, creating a Buy signal.
Fundamental Analysis of Lineage Cell Therapeutics, Inc.
Is Lineage Cell Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.23 per share.
Technical Analysis of Lineage Cell Therapeutics, Inc.
Should I short Lineage Cell Therapeutics, Inc. stock?
-
LCTX Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Lineage Cell Therapeutics, Inc. is a Buy
-
Lineage Cell Therapeutics, Inc. Relative Strength Index (RSI) is 46.3, which suggest Lineage Cell Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Lineage Cell Therapeutics, Inc. is (1.68 - 1.78), which suggest Lineage Cell Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Lineage Cell Therapeutics, Inc. is (1.25 - 1.81), which suggest Lineage Cell Therapeutics, Inc. is a Buy
* Lineage Cell Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.